OraSure Technologies (OSUR) Tops Q2 EPS by 3c, Revenues Beat; Offers 3Q EPS/Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall St rises as oil falls heading into US midterm elections, more earnings
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 6% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
- Marvell agrees to acquire Lumentum in all-stock deal valued at $115B
- Cerebras shares fall as UBS cuts price target
- Cipher Digital posts Q3 revenue of $27M, logs first HPC lease income
- Alphabet shares rise as analysts back stock after selloff
- Oracle files to offer $10B in common stock alongside senior notes
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
OraSure Announces 2018 Second Quarter Financial Results
August 8, 2018 4:05 PM EDTBETHLEHEM, Pa., Aug. 08, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the three and six months ended June 30, 2018.
Financial Highlights
Consolidated net revenues for the second quarter of 2018 were $43.6 million, a 9% increase from the second quarter of 2017. Consolidated net product revenues were $38.8 million, representing a 1% decrease from the second quarter of 2017.Consolidated net revenues for the six months ended June... More


